ProMIS Neurosciences shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.

ProMIS Neurosciences shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.